Blood Pressure and Arteries STUDIES

Highlights EVNol SupraBio™ mixed tocotrienols significantly attenuate the progression of white matter lesions in adults at risk for cardiovascular disease Effective dosage is 200 mg, twice daily, for 2 years Treatment...

Highlights ENDUR-ACIN® is an effective treatment for hyperlipidemia in patients with ischemic heart disease, especially if fibrates are contraindicated. Summary This comparison study explores the relative efficacy of long-term use...

Highlights ENDUR-ACIN® improves blood cholesterol in hyperlipidemic patients with coronary artery disease 13% reduction in total cholesterol, on average 31% increase in HDL cholesterol, on average Well tolerated with only...

Highlights ENDUR-ACIN® improves serum lipid profiles in patients with dyslididemia and hypertension. ENDUR-ACIN® helps normalize cerebrovascular tone and reactivity. ENDUR-ACIN® exerts a mild hypertensive effect. Summary This open-label trial was...

Highlights ENDUR-ACIN® improves blood lipids in patients with CAD and primary hyperlipidemia Effective dosage is 1,500 mg/day for 2 years Most patients (75%) also achieved stabilization of atherosclerosis Summary The...